When data and technology expedite growth, how can ...

In 2019, life sciences companies must accelerate . their dealmaking agendas on two fronts: ... in deal value or affect more than 50% of either company’s market share. • Megamergers. are a subset of transformative M&A with valuations above US$40 billion. ... providers are beginning to respond to Amazon’s entry into health care with ... ................
................